Wang, C.; Liang, H.; Lin, C.; Li, F.; Xie, G.; Qiao, S.; Shi, X.; Deng, J.; Zhao, X.; Wu, K.;
et al. Molecular Subtyping and Prognostic Assessment Based on Tumor Mutation Burden in Patients with Lung Adenocarcinomas. Int. J. Mol. Sci. 2019, 20, 4251.
https://doi.org/10.3390/ijms20174251
AMA Style
Wang C, Liang H, Lin C, Li F, Xie G, Qiao S, Shi X, Deng J, Zhao X, Wu K,
et al. Molecular Subtyping and Prognostic Assessment Based on Tumor Mutation Burden in Patients with Lung Adenocarcinomas. International Journal of Molecular Sciences. 2019; 20(17):4251.
https://doi.org/10.3390/ijms20174251
Chicago/Turabian Style
Wang, Changzheng, Han Liang, Cong Lin, Fuqiang Li, Guoyun Xie, Sitan Qiao, Xulian Shi, Jianlian Deng, Xin Zhao, Kui Wu,
and et al. 2019. "Molecular Subtyping and Prognostic Assessment Based on Tumor Mutation Burden in Patients with Lung Adenocarcinomas" International Journal of Molecular Sciences 20, no. 17: 4251.
https://doi.org/10.3390/ijms20174251
APA Style
Wang, C., Liang, H., Lin, C., Li, F., Xie, G., Qiao, S., Shi, X., Deng, J., Zhao, X., Wu, K., & Zhang, X.
(2019). Molecular Subtyping and Prognostic Assessment Based on Tumor Mutation Burden in Patients with Lung Adenocarcinomas. International Journal of Molecular Sciences, 20(17), 4251.
https://doi.org/10.3390/ijms20174251